Keywords
Breast cancer
Risk
Prognosis
Green tea
Black tea
Submitted : 2025-03-03
Accepted : 2025-03-18
Published : 2025-04-02
Abstract
The global incidence of breast cancer remains high and is increasing annually in some regions. Despite the variety of current treatments for breast cancer, the preventive and therapeutic effects are still limited due to the highly heterogeneous nature and complex biological mechanisms of breast cancer. In recent years, tea consumption has emerged as a research focus due to its possible anti-cancer properties. Numerous preclinical studies have demonstrated that regular tea intake could potentially curb the progression of breast cancer by influencing various biological mechanisms, including signaling pathways, cell cycle regulation, and immune system responses, among others. Nonetheless, the findings from epidemiological studies show considerable variability, and the connection between tea drinking and both the risk and outlook for breast cancer is shaped by numerous elements. These include the specific type of tea consumed, the quantity consumed, individual genetic variations, and environmental influences. This article summarizes the current research findings and delves into the connection between tea consumption and the risk as well as the prognosis of breast cancer among different regional populations. Meanwhile, it expounds on the potential molecular biological mechanisms behind it. The aim is to offer a theoretical foundation for the personalized prevention and treatment of breast cancer.
References
Bray F, Laversanne M, Sung H, et al., 2024, Global Cancer Statistics 2022: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin, 74(3): 229–263.
Lundqvist A, Andersson E, Ahlberg I, et al., 2016, Socioeconomic Inequalities in Breast Cancer Incidence and Mortality in Europe: A Systematic Review and Meta-Analysis. Eur J Public Health, 26(5): 804–813.
Lukasiewicz S, Czeczelewski M, Forma A, et al., 2021. Breast Cancer Epidemiology, Risk Factors, Classification, Prognostic Markers, and Current Treatment Strategies: An Updated Review. Cancers (Basel), 13(17): 4287.
Luo Q, Luo L, Zhao J, et al., 2024, Biological Potential and Mechanisms of Tea’s Bioactive Compounds: An Updated Review. J Adv Res, 65: 345–363.
Yuan JM, Sun C, Butler LM, 2011, Tea and Cancer Prevention: Epidemiological Studies. Pharmacol Res, 64(2): 123–135.
Yue Y, Chu GX, Liu XS, et al., 2014, TMDB: A Literature-Curated Database for Small Molecular Compounds Found from Tea. BMC Plant Biol, 14: 243.
Tang GY, Meng X, Gan RY, et al., 2019, Health Functions and Related Molecular Mechanisms of Tea Components: An Update Review. Int J Mol Sci, 20(24): 6196.
Liu Y, Zhao G, Li X, et al., 2020, Comparative Analysis of Phenolic Compound Metabolism among Tea Plants in the Section Thea of the Genus Camellia. Food Res Int, 135: 109276.
Ramadan G, El-Beih NM, Talaat RM, et al., 2017, Anti-Inflammatory Activity of Green Versus Black Tea Aqueous Extract in a Rat Model of Human Rheumatoid Arthritis. Int J Rheum Dis, 20(2): 203–213.
Brimson JM, Prasanth MI, Kumaree KK, et al., 2022, Tea Plant (Camellia sinensis): A Current Update on Use in Diabetes, Obesity, and Cardiovascular Disease. Nutrients, 15(1): 37.
Liu S, Zhang Q, Li H, et al., 2022, Comparative Assessment of the Antibacterial Efficacies and Mechanisms of Different Tea Extracts. Foods, 11(4): 620.
Farhan M, 2022, Green Tea Catechins: Nature’s Way of Preventing and Treating Cancer. Int J Mol Sci, 23(18): 10713.
Mao X, Xiao X, Chen D, et al., 2019, Tea and Its Components Prevent Cancer: A Review of the Redox-Related Mechanism. Int J Mol Sci, 20(21): 5249.
Khan N, Mukhtar H, 2018, Tea Polyphenols in Promotion of Human Health. Nutrients, 11(1): 39.
Boehm K, Borrelli F, Ernst E, et al., 2009, Green Tea (Camellia sinensis) for the Prevention of Cancer. Cochrane Database Syst Rev, 2009(3): CD005004.
Najaf Najafi M, Salehi M, Ghazanfarpour M, et al., 2018, The Association Between Green Tea Consumption and Breast Cancer Risk: A Systematic Review and Meta-Analysis. Phytother Res, 32(10): 1855–1864.
Ogunleye AA, Xue F, Michels KB, 2010, Green Tea Consumption and Breast Cancer Risk or Recurrence: A Meta-Analysis. Breast Cancer Res Treat, 119(2): 477–484.
Ewertz M, Gill C, 1990, Dietary Factors and Breast-Cancer Risk in Denmark. Int J Cancer, 46(5): 779–784.
Goldbohm RA, Hertog MG, Brants HA, et al., 1996, Consumption of Black Tea and Cancer Risk: A Prospective Cohort Study. J Natl Cancer Inst, 88(2): 93–100.
Michels KB, Holmberg L, Bergkvist L, et al., 2002, Coffee, Tea, and Caffeine Consumption and Breast Cancer Incidence in a Cohort of Swedish Women. Ann Epidemiol, 12(1): 21–26.
Oh JK, Sandin S, Strom P, et al., 2015, Prospective Study of Breast Cancer in Relation to Coffee, Tea and Caffeine in Sweden. Int J Cancer, 137(8): 1979–1989.
Hirvonen T, Mennen LI, de Bree A, et al., 2006, Consumption of Antioxidant-Rich Beverages and Risk for Breast Cancer in French Women. Ann Epidemiol, 16(7): 503–508.
Fagherazzi G, Touillaud MS, Boutron-Ruault MC, et al., 2011, No Association between Coffee, Tea or Caffeine Consumption and Breast Cancer Risk in a Prospective Cohort Study. Public Health Nutr, 14(7): 1315–1320.
Zheng W, Doyle TJ, Kushi LH, et al., 1996, Tea Consumption and Cancer Incidence in a Prospective Cohort Study of Postmenopausal Women. Am J Epidemiol, 144(2): 175–182.
Adebamowo CA, Cho E, Sampson L, et al., 2005, Dietary Flavonols and Flavonol-Rich Foods Intake and the Risk of Breast Cancer. Int J Cancer, 114(4): 628–633.
Ganmaa D, Willett WC, Li TY, et al., 2008, Coffee, Tea, Caffeine and Risk of Breast Cancer: A 22-Year Follow-Up. Int J Cancer, 122(9): 2071–2076.
Boggs DA, Palmer JR, Stampfer MJ, et al., 2010, Tea and Coffee Intake in Relation to Risk of Breast Cancer in the Black Women’s Health Study. Cancer Causes Control, 21(11): 1941–1948.
Zhang D, Nichols HB, Troester M, et al., 2020, Tea Consumption and Breast Cancer Risk in a Cohort of Women with Family History of Breast Cancer. Int J Cancer, 147(3): 876–886.
Arthur R, Kirsh VA, Rohan TE, 2018, Associations of Coffee, Tea and Caffeine Intake with Risk of Breast, Endometrial and Ovarian Cancer among Canadian Women. Cancer Epidemiol, 56: 75–82.
Ronco AL, Stefani ED, Mendoza B, et al., 2016, Mate and Tea Intake, Dietary Antioxidants and Risk of Breast Cancer: A Case-Control Study. Asian Pac J Cancer Prev, 17(6): 2923–2933.
Wu AH, Yu MC, Tseng CC, et al., 2003, Green Tea and Risk of Breast Cancer in Asian Americans. Int J Cancer, 106(4): 574–579.
Suzuki Y, Tsubono Y, Nakaya N, et al., 2004, Green Tea and the Risk of Breast Cancer: Pooled Analysis of Two Prospective Studies in Japan. Br J Cancer, 90(7): 1361–1363.
Iwasaki M, Inoue M, Sasazuki S, et al., 2010, Green Tea Drinking and Subsequent Risk of Breast Cancer in a Population-Based Cohort of Japanese Women. Breast Cancer Res, 12(5): R88.
Mizoo T, Taira N, Nishiyama K, et al., 2013, Effects of Lifestyle and Single Nucleotide Polymorphisms on Breast Cancer Risk: A Case-Control Study in Japanese Women. BMC Cancer, 13: 565.
Yuan JM, Koh WP, Sun CL, et al., 2005, Green Tea Intake, ACE Gene Polymorphism and Breast Cancer Risk among Chinese Women in Singapore. Carcinogenesis, 26(8): 1389–1394.
Inoue M, Robien K, Wang R, et al., 2008, Green Tea Intake, MTHFR/TYMS Genotype and Breast Cancer Risk: The Singapore Chinese Health Study. Carcinogenesis, 29(10): 1967–1972.
Zhang M, Holman CD, Huang JP, et al., 2007, Green Tea and the Prevention of Breast Cancer: A Case-Control Study in Southeast China. Carcinogenesis, 28(5): 1074–1078.
Li X, Yu C, Guo Y, et al., 2019, Association between Tea Consumption and Risk of Cancer: A Prospective Cohort Study of 0.5 Million Chinese Adults. Eur J Epidemiol, 34(8): 753–763.
Fuhrman BJ, Pfeiffer RM, Wu AH, et al., 2013, Green Tea Intake is Associated with Urinary Estrogen Profiles in Japanese-American Women. Nutr J, 12: 25.
Larsson SC, Bergkvist L, Wolk A, 2009, Coffee and Black Tea Consumption and Risk of Breast Cancer by Estrogen and Progesterone Receptor Status in a Swedish Cohort. Cancer Causes Control, 20(10): 2039–2044.
Bhoo-Pathy N, Peeters PH, Uiterwaal CS, et al., 2015, Coffee and Tea Consumption and Risk of Pre- and Postmenopausal Breast Cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) Cohort Study. Breast Cancer Res, 17(1): 15.
Shrubsole MJ, Lu W, Chen Z, et al., 2009, Drinking Green Tea Modestly Reduces Breast Cancer Risk. J Nutr, 139(2): 310–316.
Li M, Tse LA, Chan WC, et al., 2016, Evaluation of Breast Cancer Risk Associated with Tea Consumption by Menopausal and Estrogen Receptor Status among Chinese Women in Hong Kong. Cancer Epidemiol, 40: 73–78.
Iwasaki M, Mizusawa J, Kasuga Y, et al., 2014, Green Tea Consumption and Breast Cancer Risk in Japanese Women: A Case-Control Study. Nutr Cancer, 66(1): 57–67.
Torres-Sanchez L, Lopez-Carrillo L, Lopez-Cervantes M, et al., 2000, Food Sources of Phytoestrogens and Breast Cancer Risk in Mexican Women. Nutr Cancer, 37(2): 134–139.
Kumar N, Titus-Ernstoff L, Newcomb PA, et al., 2009, Tea Consumption and Risk of Breast Cancer. Cancer Epidemiol Biomarkers Prev, 18(1): 341–345.
Wu AH, Yu MC, 2006, Tea, Hormone-Related Cancers and Endogenous Hormone Levels. Mol Nutr Food Res, 50(2): 160–169.
Nakachi K, Suemasu K, Suga K, et al., 1998, Influence of Drinking Green Tea on Breast Cancer Malignancy among Japanese Patients. Jpn J Cancer Res, 89(3): 254–261.
Inoue M, Tajima K, Mizutani M, et al., 2001, Regular Consumption of Green Tea and the Risk of Breast Cancer Recurrence: Follow-Up Study from the Hospital-Based Epidemiologic Research Program at Aichi Cancer Center (HERPACC), Japan. Cancer Lett, 167(2): 175–182.
Seely D, Mills EJ, Wu P, et al., 2005, The Effects of Green Tea Consumption on Incidence of Breast Cancer and Recurrence of Breast Cancer: A Systematic Review and Meta-Analysis. Integr Cancer Ther, 4(2): 144–155.
Harris HR, Bergkvist L, Wolk A, 2012, Coffee and Black Tea Consumption and Breast Cancer Mortality in a Cohort of Swedish Women. Br J Cancer, 107(5): 874–878.
Farvid MS, Spence ND, Rosner BA, et al., 2021, Post-Diagnostic Coffee and Tea Consumption and Breast Cancer Survival. Br J Cancer, 124(11): 1873–1881.
Bao PP, Zhao GM, Shu XO, et al., 2015, Modifiable Lifestyle Factors and Triple-Negative Breast Cancer Survival: A Population-Based Prospective Study. Epidemiology, 26(6): 909–916.
Zhang JY, Liao YH, Lin Y, et al., 2019, Effects of Tea Consumption and the Interactions with Lipids on Breast Cancer Survival. Breast Cancer Res Treat, 176(3): 679–686.
Suzuki K, Morishita S, Nakano J, et al., 2024, Association between Quality of Life and Mortality Risk in Patients with Breast Cancer: A Systematic Review and Meta-Analysis. Breast Cancer, 31(4): 552–561.
Soldato D, Havas J, Crane TE, et al., 2022, Coffee and Tea Consumption, Patient-Reported, and Clinical Outcomes in a Longitudinal Study of Patients with Breast Cancer. Cancer, 128(19): 3552–3563.
Ahles TA, Root JC, Ryan EL, 2012, Cancer- and Cancer Treatment-Associated Cognitive Change: An Update on the State of the Science. J Clin Oncol, 30(30): 3675–3686.
Dietrich J, Monje M, Wefel J, et al., 2008, Clinical Patterns and Biological Correlates of Cognitive Dysfunction Associated with Cancer Therapy. Oncologist, 13(12): 1285–1295.
Koppelmans V, Breteler MM, Boogerd W, et al., 2013, Late Effects of Adjuvant Chemotherapy for Adult Onset Non-CNS Cancer; Cognitive Impairment, Brain Structure and Risk of Dementia. Crit Rev Oncol Hematol, 88(1): 87–101.
Huang Z, Shi Y, Bao P, et al., 2018, Associations of Dietary Intake and Supplement Use with Post-Therapy Cognitive Recovery in Breast Cancer Survivors. Breast Cancer Res Treat, 171(1): 189–198.
Yan Z, Zhong Y, Duan Y, et al., 2020, Antioxidant Mechanism of Tea Polyphenols and its Impact on Health Benefits. Anim Nutr, 6(2): 115–123.
Yang CS, Kim S, Yang GY, et al., 1999, Inhibition of Carcinogenesis by Tea: Bioavailability of Tea Polyphenols and Mechanisms of Actions. Proc Soc Exp Biol Med, 220(4): 213–217.
Krishnamurti U, Silverman JF, 2014, HER2 in Breast Cancer: A Review and Update. Adv Anat Pathol, 21(2): 100–107.
Masuda M, Suzui M, Lim JT, 2003, Epigallocatechin-3-Gallate Inhibits Activation of HER-2/neu and Downstream Signaling Pathways in Human Head and Neck and Breast Carcinoma Cells. Clin Cancer Res, 9(9): 3486–3491.
De Amicis F, Russo A, Avena P, et al., 2013, In Vitro Mechanism for Downregulation of ER-α Expression by Epigallocatechin Gallate in ER+/PR+ Human Breast Cancer Cells. Mol Nutr Food Res, 57(5): 840–853.
Kim J, Zhang X, Rieger-Christ KM, et al., 2006, Suppression of Wnt Signaling by the Green Tea Compound (-)-Epigallocatechin 3-Gallate (EGCG) in Invasive Breast Cancer Cells. Requirement of the Transcriptional Repressor HBP1. J Biol Chem, 281(16): 10865–10875.
Lee WJ, Cheng TC, Yen Y, et al., 2021, Tea Polyphenol Epigallocatechin-3-Gallate Inhibits Cell Proliferation in a Patient-Derived Triple-Negative Breast Cancer Xenograft Mouse Model Via Inhibition of Proline-Dehydrogenase-Induced Effects. J Food Drug Anal, 29(1): 113–127.
Kim SH, Hwang KA, Choi KC, 2016, Treatment with Kaempferol Suppresses Breast Cancer Cell Growth Caused by Estrogen and Triclosan in Cellular and Xenograft Breast Cancer Models. J Nutr Biochem, 28: 70–82.
Rathore K, Choudhary S, Odoi A, et al., 2012, Green Tea Catechin Intervention of Reactive Oxygen Species-Mediated ERK Pathway Activation and Chronically Induced Breast Cell Carcinogenesis. Carcinogenesis, 33(1): 174–183.
Latronico T, Petraglia T, Sileo C, et al., 2024, Inhibition of MMP-2 and MMP-9 by Dietary Antioxidants in THP-1 Macrophages and Sera from Patients with Breast Cancer. Molecules, 29(8): 1718.
Gonzalez Suarez N, Fernandez-Marrero Y, Torabidastgerdooei S, et al., 2022, EGCG Prevents the Onset of an Inflammatory and Cancer-Associated Adipocyte-Like Phenotype in Adipose-Derived Mesenchymal Stem/Stromal Cells in Response to the Triple-Negative Breast Cancer Secretome. Nutrients, 14(5): 1099.
Le Querrec A, Duval D, Tobelem G, 1993, Tumour Angiogenesis. Baillieres Clin Haematol, 6(3): 711–730.
Sartippour MR, Heber D, Ma J, et al., 2001, Green Tea and its Catechins Inhibit Breast Cancer Xenografts. Nutr Cancer, 40(2): 149–156.
Sartippour MR, Shao ZM, Heber D, et al., 2002, Green Tea Inhibits Vascular Endothelial Growth Factor (VEGF) Induction in Human Breast Cancer Cells. J Nutr, 132(8): 2307–2311.
Leong H, Mathur PS, Greene GL, 2009, Green Tea Catechins Inhibit Angiogenesis Through Suppression of STAT3 Activation. Breast Cancer Res Treat, 117(3): 505–515.
Sartippour MR, Heber D, Zhang L, et al., 2002, Inhibition of Fibroblast Growth Factors by Green Tea. Int J Oncol, 21(3): 487–491.
Belguise K, Guo S, Sonenshein GE, 2007, Activation of FOXO3a by the Green Tea Polyphenol Epigallocatechin-3-Gallate Induces Estrogen Receptor Alpha Expression Reversing Invasive Phenotype of Breast Cancer Cells. Cancer Res, 67(12): 5763–5770.
Thangapazham RL, Passi N, Maheshwari RK, 2007, Green Tea Polyphenol and Epigallocatechin Gallate Induce Apoptosis and Inhibit Invasion in Human Breast Cancer Cells. Cancer Biol Ther, 6(12): 1938–1943.
Sen T, Chatterjee A, 2011, Epigallocatechin-3-Gallate (EGCG) Downregulates EGF-Induced MMP-9 in Breast Cancer Cells: Involvement of Integrin Receptor α5β1 in the Process. Eur J Nutr, 50(6): 465–478.
Zhang Y, Han G, Fan B, et al., 2009, Green Tea (-)-Epigallocatechin-3-Gallate Down-Regulates VASP Expression and Inhibits Breast Cancer Cell Migration and Invasion by Attenuating Rac1 Activity. Eur J Pharmacol, 606(1–3): 172–179.
Kuhajda FP, 2000, Fatty-Acid Synthase and Human Cancer: New Perspectives on its Role in Tumor Biology. Nutrition, 16(3): 202–208.
Yeh CW, Chen WJ, Chiang CT, et al., 2003, Suppression of Fatty Acid Synthase in MCF-7 Breast Cancer Cells by Tea and Tea Polyphenols: A Possible Mechanism for their Hypolipidemic Effects. Pharmacogenomics J, 3(5): 267–276.
Wei R, Mao L, Xu P, et al., 2018, Suppressing Glucose Metabolism with Epigallocatechin-3-Gallate (EGCG) Reduces Breast Cancer Cell Growth in Preclinical Models. Food Funct, 9(11): 5682–5696.
Xu P, Yan F, Zhao Y, et al., 2020, Green Tea Polyphenol EGCG Attenuates MDSCs-Mediated Immunosuppression through Canonical and Non-Canonical Pathways in a 4T1 Murine Breast Cancer Model. Nutrients, 12(4): 1042.
Deb G, Thakur VS, Limaye AM, et al., 2015, Epigenetic Induction of Tissue Inhibitor of Matrix Metalloproteinase-3 by Green Tea Polyphenols in Breast Cancer Cells. Mol Carcinog, 54(6): 485–499.
Sheng J, Shi W, Guo H, et al., 2019, The Inhibitory Effect of (-)-Epigallocatechin-3-Gallate on Breast Cancer Progression via Reducing SCUBE2 Methylation and DNMT Activity. Molecules, 24(16): 2899.
Planas-Silva MD, Weinberg RA, 1997, The Restriction Point and Control of Cell Proliferation. Curr Opin Cell Biol, 9(6): 768–772.
Liberto M, Cobrinik D, 2000, Growth Factor-Dependent Induction of p21(CIP1) by the Green Tea Polyphenol, Epigallocatechin Gallate. Cancer Lett, 154(2): 151–161.
Vergote D, Cren-Olive C, Chopin V, et al., 2002, (-)-Epigallocatechin (EGC) of Green Tea Induces Apoptosis of Human Breast Cancer Cells but Not of Their Normal Counterparts. Breast Cancer Res Treat, 76(3): 195–201.
Herbert BS, Wright WE, Shay JW, 2001, Telomerase and Breast Cancer. Breast Cancer Res, 3(3): 146–149.
Mittal A, Pate MS, Wylie RC, et al., 2004, EGCG Down-Regulates Telomerase in Human Breast Carcinoma MCF-7 Cells, Leading to Suppression of Cell Viability and Induction of Apoptosis. Int J Oncol, 24(3): 703–710.
Chen X, Li Y, Lin Q, et al., 2014, Tea Polyphenols Induced Apoptosis of Breast Cancer Cells by Suppressing the Expression of Survivin. Sci Rep, 4: 4416.
Tang Y, Zhao DY, Elliott S, et al., 2007, Epigallocatechin-3 Gallate Induces Growth Inhibition and Apoptosis in Human Breast Cancer Cells Through Survivin Suppression. Int J Oncol, 31(4): 705–711.
Lahiry L, Saha B, Chakraborty J, et al., 2008, Contribution of p53-Mediated Bax Transactivation in Theaflavin-Induced Mammary Epithelial Carcinoma Cell Apoptosis. Apoptosis, 13(6): 771–781.
Li W, He N, Tian L, et al., 2016, Inhibitory Effects of Polyphenol-Enriched Extract from Ziyang Tea against Human Breast Cancer MCF-7 Cells through Reactive Oxygen Species-Dependent Mitochondria Molecular Mechanism. J Food Drug Anal, 24(3): 527–538.
Thomas P, Dong J, 2021, (-)-Epicatechin Acts as a Potent Agonist of the Membrane Androgen Receptor, ZIP9 (SLC39A9), to Promote Apoptosis of Breast and Prostate Cancer Cells. J Steroid Biochem Mol Biol, 211: 105906.
Zhao Y, Ding ZG, Yan YJ, et al., 2024, Teadenol B as a Component of Microorganism-Fermented Tea Extract Inhibited Breast Cancers by Promoting Autophagy. Molecules, 29(4): 872.
Hsuuw YD, Chan WH, 2007, Epigallocatechin Gallate Dose-Dependently Induces Apoptosis or Necrosis in Human MCF-7 Cells. Ann N Y Acad Sci, 1095: 428–440.
Tian Y, Lei Y, Wang Y, et al., 2023, Mechanism of Multidrug Resistance to Chemotherapy Mediated by P‑Glycoprotein (Review). Int J Oncol, 63(5): 119.
Zhu A, Wang X, Guo Z, 2001, Study of Tea Polyphenol as a Reversal Agent for Carcinoma Cell Lines’ Multidrug Resistance (Study of TP as a MDR Reversal Agent). Nucl Med Biol, 28(6): 735–740.
Farabegoli F, Papi A, Orlandi M, 2011, (-)-Epigallocatechin-3-Gallate Down-Regulates EGFR, MMP-2, MMP-9 and EMMPRIN and Inhibits the Invasion of MCF-7 Tamoxifen-Resistant Cells. Biosci Rep, 31(2): 99–108.
Sartippour MR, Pietras R, Marquez-Garban DC, et al., 2006, The Combination of Green Tea and Tamoxifen is Effective Against Breast Cancer. Carcinogenesis, 27(12): 2424–2433.
Li Y, Yuan YY, Meeran SM, et al., 2010, Synergistic Epigenetic Reactivation of Estrogen Receptor-α (ERα) by Combined Green Tea Polyphenol and Histone Deacetylase Inhibitor in ERα-Negative Breast Cancer Cells. Mol Cancer, 9: 274.
Tyagi T, Treas JN, Mahalingaiah PK, et al., 2015, Potentiation of Growth Inhibition and Epigenetic Modulation by Combination of Green Tea Polyphenol and 5-Aza-2’-Deoxycytidine in Human Breast Cancer Cells. Breast Cancer Res Treat, 149(3): 655–668.
Li Y, Buckhaults P, Cui X, et al., 2016, Combinatorial Epigenetic Mechanisms and Efficacy of Early Breast Cancer Inhibition by Nutritive Botanicals. Epigenomics, 8(8): 1019–1037.
Zhou Y, Tang J, Du Y, et al., 2016, The Green Tea Polyphenol EGCG Potentiates the Antiproliferative Activity of Sunitinib in Human Cancer Cells. Tumour Biol, 37(7): 8555–8566.